Clinical impact of pancytopenia in hospitalized patients [PDF]
Objetivo: Determinar etiología, manifestaciones clínicas, morbimortalidad y recursos diagnósticos y terapéuticos utilizados en pacientes internados con pancitopenia.
Carena, José Alberto+5 more
core
Incidence of aplastic anemia and agranulocytosis in Latin America: the LATIN study
CONTEXT AND OBJECTIVE: Aplastic anemia and agranulocytosis are rare but life-threatening disorders, often caused by drugs and other environmental exposures.
Nelson Hamerschlak+11 more
doaj +1 more source
Brief Report: Development of Aplastic Anemia and the Exposure to Stoddard Solvent [PDF]
David Prager, Charles Peters
openalex +1 more source
Modern concepts of the platelet in health and disease [PDF]
Thesis (M.D.)--Boston ...
Estes, J. Worth
core
CLINICAL APPLICABILITY OF PROPOSED ALGORITHM FOR IDENTIFYING INDIVIDUALS AT RISK FOR HEREDITARY HEMATOLOGIC MALIGNANCIES [PDF]
Over the past decade, more than 12 genes have been identified to cause hereditary predispositions to hematologic malignancies. These syndromes are characterized by an increased risk to develop myelodysplastic syndrome (MDS), acute myeloid leukemia (AML),
Clifford, Maggie
core +1 more source
Editorial: The pathogenesis of aplastic anemia: a defective pluripotent hematopoietic stem cell with inappropriate balance of differentiation and self-replication [PDF]
DR Boggs, S. S. Boggs
openalex +1 more source
BONE MARROW TRANSPLANTATION IN CHILDREN WITH APLASTIC ANEMIA [PDF]
L. J. Dooren+2 more
openalex +1 more source
Aplastic Anemia with Ethosuximide
An 8-year-old girl who developed aplastic anemia after 8 months ethosuximide therapy for absence seizures is reported from the Children’s Medical College of Virginia, Richmond, VA.
openaire +4 more sources
Aplastic anemia secondary to adjuvant Osimertinib therapy: a case report and a review of literature
Aplastic anemia is a rare hematological disorder characterized by suppressed hematopoiesis and pancytopenia. Although several drugs have been associated with aplastic anemia, its occurrence in response to Osimertinib, a third-generation epidermal growth ...
Ahmed Abdalhadi+7 more
doaj +1 more source